APOE and dementia: Compared with APOE ɛ4 noncarriers with stable BMI, APOE ɛ4 carriers with large BMI loss (HR = 6.66, 95% CI 2.83−14.4) or gain (HR = 9.93, 95% CI 3.49–24.6) had higher dementia risk.